Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 55Leukemia, Myeloid, Acute 54Myelodysplastic Syndromes 46Leukemia 36Lymphoma, Non-Hodgkin 29Leukemia, Myelogenous, Chronic, BCR-ABL Positive 25Lymphoma 23Hematologic Neoplasms 20Hodgkin Disease 19Leukemia, Lymphocytic, Chronic, B-Cell 17Burkitt Lymphoma 14Leukemia, Myeloid, Accelerated Phase 13Leukemia, Biphenotypic, Acute 13Blast Crisis 12Multiple Myeloma 11Congenital Abnormalities 11Myeloproliferative Disorders 10Lymphoma, Large-Cell, Immunoblastic 10Lymphoma, Follicular 10Graft vs Host Disease 10Anemia, Refractory, with Excess of Blasts 10Lymphoma, Mantle-Cell 9Lymphoma, Large B-Cell, Diffuse 9Leukemia, Myeloid, Chronic-Phase 9Dendritic Cell Sarcoma, Interdigitating 9Lymphoma, B-Cell, Marginal Zone 8Leukemia, Myelomonocytic, Juvenile 8Recurrence 7Leukemia, Myelomonocytic, Chronic 7Myelodysplastic-Myeloproliferative Diseases 6

Interventions

fludarabine phosphate 2fludarabine 2AP 1903 reagent 2ruxolitinib 1Whole-Body Irradiation 1Thiotepa 1Peripheral Blood Stem Cell Transplantation 1Panobinostat 1Melphalan 1Cyclophosphamide 1Clofarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thalassemia × Thiotepa × Other hematologic neoplasm × Clear all
NCT03609840 2023-09-21

Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients

University of California, San Francisco

Completed
25 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Sickle Cell, Fanconi Anemia, Hemoglobinopathies, Immunologic Deficiency Syndromes, Thalassemia, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡